探究抗菌药物对乌干达男性阴茎微生物群、免疫及HIV易感性影响的随机临床试验方案
这项开放标签随机对照试验将125名寻求自愿包皮环切的HIV阴性乌干达男性随机分为5组(每组25人),对照组立即行包皮环切,四个干预组延迟1个月并分别接受口服替硝唑、阴茎局部甲硝唑、局部克林霉素或局部过氧化氢。主要终点为包皮环切时通过假病毒试验体外定量HIV进入包皮来源CD4+ T细胞的情况;次要终点包括抗菌药物对免疫参数及参与者阴茎和女性伴侣阴道微生物群的影响。
要点
- 试验纳入125名HIV阴性乌干达男性,随机分为5组,每组25人。
- 对照组立即行包皮环切,干预组延迟1个月并接受不同抗菌药物。
- 主要终点为体外定量HIV进入包皮来源CD4+ T细胞。
核心结论
- 该试验将探究包皮微生物群对HIV易感性的因果作用及简单微生物群聚焦临床干预的影响。
- 作者认为这可能为未来使用低成本、非手术干预降低未行包皮环切异性恋男性HIV风险的临床试验铺平道路。
研究设计与样本
- 随机、开放标签临床试验,将125名寻求自愿包皮环切的HIV阴性乌干达男性随机分配至5组(每组25人)。
- 对照组立即行包皮环切,四个干预组延迟包皮环切1个月,期间分别接受口服替硝唑、阴茎局部甲硝唑、局部克林霉素或局部过氧化氢。
主要发现
- 主要终点为包皮环切时使用A亚型、R5嗜性HIV假病毒试验体外定量HIV进入包皮来源CD4+ T细胞的情况。
- 次要终点包括通过多重酶联免疫吸附试验和16S rRNA测序评估抗菌药物对免疫参数及参与者阴茎和女性伴侣(如适用)阴道微生物群的影响。
局限性
- 该试验为回顾性注册:ClinicalTrials.gov NCT03412071,于2018年1月26日回顾性注册。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The foreskin is the main site of HIV acquisition in a heterosexual uncircumcised man, but many men in endemic countries are reluctant to undergo penile circumcision (PC). Observational studies suggest that proinflammatory anaerobic bacteria are enriched on the uncircumcised penis, where they may enhance HIV susceptibility through increased foreskin inflammatory cytokines and the recruitment of HIV-susceptible CD4+ target cells. This trial will examine the impact of systemic and topical antimicrobials on ex vivo foreskin HIV susceptibility. METHODS/DESIGN: This randomized, open-label clinical trial will randomize 125 HIV-negative Ugandan men requesting voluntary PC to one of five arms (n = 25 each). The control group will receive immediate PC, while the four intervention groups will defer PC for 1 month and be provided in the interim with either oral tinidazole, penile topical metronidazole, topical clindamycin, or topical hydrogen peroxide. The impact of these interventions on HIV entry into foreskin-derived CD4+ T cells will be quantified ex vivo at the time of PC using a clade A, R5 tropic HIV pseudovirus assay (primary endpoint); secondary endpoints include the impact of antimicrobials on immune parameters and the microbiota of the participant's penis and of the vagina of their female partner (if applicable), assessed by multiplex enzyme-linked immunosorbent assay and 16S rRNA sequencing. DISCUSSION: There is a critical need to develop acceptable, simple, and effective means of HIV prevention in men unwilling to undergo PC. This trial will provide insight into the causative role of the foreskin microbiota on HIV susceptibility, and the impact of simple microbiota-focused clinical interventions. This may pave the way for future clinical trials using low-cost, nonsurgical intervention(s) to reduce HIV risk in uncircumcised heterosexual men. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03412071 . Retrospectively registered on 26 January 2018.
引用
- Galiwango RM, Bagaya B, Mpendo J, et al. Protocol for a randomized clinical trial exploring the effect of antimicrobial agents on the penile microbiota, immunology and HIV susceptibility of Ugandan men. Trials. 2019. PMID: 31324206. doi:10.1186/s13063-019-3545-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。